(FLEX) Flex - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: SG9999000020
Stock: Electronics, Devices, Systems, Manufacturing, Supply
Total Rating 58
Risk 80
Buy Signal -0.21
| Risk 5d forecast | |
|---|---|
| Volatility | 49.0% |
| Relative Tail Risk | -8.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.48 |
| Alpha | 47.76 |
| Character TTM | |
|---|---|
| Beta | 1.592 |
| Beta Downside | 1.625 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.99% |
| CAGR/Max DD | 1.46 |
EPS (Earnings per Share)
Revenue
Description: FLEX Flex March 04, 2026
Flex Ltd. provides technology, supply chain, and manufacturing solutions across diverse industries. The company operates in the Electronic Manufacturing Services sector, which involves outsourced manufacturing for technology companies.
Its two segments are Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). FAS focuses on high-volume products like consumer devices and communications infrastructure. FRS specializes in complex products for critical environments such as industrial, automotive, and healthcare sectors.
Flex offers comprehensive services including design, engineering, supply chain management, and logistics, operating globally across the Americas, Asia, and Europe. Investors interested in supply chain integrators may find further research on ValueRay beneficial.
Headlines to watch out for
- Global demand for data center and cloud infrastructure drives revenue.
- Automotive sector growth impacts Flex Reliability Solutions segment.
- Supply chain disruptions increase manufacturing costs and lead times.
- Healthcare technology adoption boosts medical device manufacturing.
- Economic downturns reduce consumer electronics and industrial demand.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 852.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.77 > 1.0 |
| NWC/Revenue: 16.01% < 20% (prev 15.55%; Δ 0.46% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.71b > Net Income 852.0m |
| Net Debt (2.54b) to EBITDA (1.76b): 1.45 < 3 |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (376.0m) vs 12m ago -4.57% < -2% |
| Gross Margin: 9.07% > 18% (prev 0.07%; Δ 900.5% > 0.5%) |
| Asset Turnover: 137.3% > 50% (prev 130.9%; Δ 6.38% > 0%) |
| Interest Coverage Ratio: 4.55 > 6 (EBITDA TTM 1.76b / Interest Expense TTM 207.0m) |
Altman Z'' 2.33
| A: 0.21 (Total Current Assets 15.15b - Total Current Liabilities 10.86b) / Total Assets 20.82b |
| B: 0.09 (Retained Earnings 1.91b / Total Assets 20.82b) |
| C: 0.05 (EBIT TTM 942.0m / Avg Total Assets 19.55b) |
| D: 0.34 (Book Value of Equity 5.32b / Total Liabilities 15.70b) |
| Altman-Z'' Score: 2.33 = BBB |
Beneish M -3.44
| DSRI: 0.85 (Receivables 3.84b/4.01b, Revenue 26.84b/23.92b) |
| GMI: 0.72 (GM 9.07% / 6.55%) |
| AQI: 0.85 (AQ_t 0.13 / AQ_t-1 0.15) |
| SGI: 1.12 (Revenue 26.84b / 23.92b) |
| TATA: -0.04 (NI 852.0m - CFO 1.71b) / TA 20.82b) |
| Beneish M-Score: -3.44 (Cap -4..+1) = AA |
What is the price of FLEX shares?
As of March 11, 2026, the stock is trading at USD 60.91 with a total of 2,846,417 shares traded.
Over the past week, the price has changed by -3.44%, over one month by -5.26%, over three months by -15.50% and over the past year by +85.02%.
Over the past week, the price has changed by -3.44%, over one month by -5.26%, over three months by -15.50% and over the past year by +85.02%.
Is FLEX a buy, sell or hold?
Flex has received a consensus analysts rating of 4.45.
Therefore, it is recommended to buy FLEX.
- StrongBuy: 6
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FLEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.1 | 25% |
| Analysts Target Price | 76.1 | 25% |
FLEX Fundamental Data Overview March 10, 2026
P/E Trailing = 26.8655
P/E Forward = 16.2866
P/S = 0.8256
P/B = 4.2999
P/EG = 0.9351
Revenue TTM = 26.84b USD
EBIT TTM = 942.0m USD
EBITDA TTM = 1.76b USD
Long Term Debt = 3.76b USD (from longTermDebt, last quarter)
Short Term Debt = 675.0m USD (from shortTermDebt, last quarter)
Debt = 5.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.54b USD (from netDebt column, last quarter)
Enterprise Value = 24.70b USD (22.15b + Debt 5.60b - CCE 3.06b)
Interest Coverage Ratio = 4.55 (Ebit TTM 942.0m / Interest Expense TTM 207.0m)
EV/FCF = 21.25x (Enterprise Value 24.70b / FCF TTM 1.16b)
FCF Yield = 4.70% (FCF TTM 1.16b / Enterprise Value 24.70b)
FCF Margin = 4.33% (FCF TTM 1.16b / Revenue TTM 26.84b)
Net Margin = 3.17% (Net Income TTM 852.0m / Revenue TTM 26.84b)
Gross Margin = 9.07% ((Revenue TTM 26.84b - Cost of Revenue TTM 24.40b) / Revenue TTM)
Gross Margin QoQ = 9.71% (prev 9.02%)
Tobins Q-Ratio = 1.19 (Enterprise Value 24.70b / Total Assets 20.82b)
Interest Expense / Debt = 1.04% (Interest Expense 58.0m / Debt 5.60b)
Taxrate = 25.31% (81.0m / 320.0m)
NOPAT = 703.6m (EBIT 942.0m * (1 - 25.31%))
Current Ratio = 1.40 (Total Current Assets 15.15b / Total Current Liabilities 10.86b)
Debt / Equity = 1.09 (Debt 5.60b / totalStockholderEquity, last quarter 5.12b)
Debt / EBITDA = 1.45 (Net Debt 2.54b / EBITDA 1.76b)
Debt / FCF = 2.19 (Net Debt 2.54b / FCF TTM 1.16b)
Total Stockholder Equity = 5.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.36% (Net Income 852.0m / Total Assets 20.82b)
RoE = 16.83% (Net Income TTM 852.0m / Total Stockholder Equity 5.06b)
RoCE = 10.68% (EBIT 942.0m / Capital Employed (Equity 5.06b + L.T.Debt 3.76b))
RoIC = 7.87% (NOPAT 703.6m / Invested Capital 8.94b)
WACC = 9.56% (E(22.15b)/V(27.76b) * Re(11.78%) + D(5.60b)/V(27.76b) * Rd(1.04%) * (1-Tc(0.25)))
Discount Rate = 11.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.14%
[DCF] Terminal Value 76.37% ; FCFF base≈1.23b ; Y1≈1.52b ; Y5≈2.59b
[DCF] Fair Price = 83.53 (EV 33.26b - Net Debt 2.54b = Equity 30.71b / Shares 367.7m; r=9.56% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 42.45 | EPS CAGR: 14.71% | SUE: 1.45 | # QB: 1
Revenue Correlation: -32.56 | Revenue CAGR: 0.80% | SUE: 0.95 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.83 | Chg7d=+0.021 | Chg30d=+0.020 | Revisions Net=+4 | Analysts=6
EPS next Year (2027-03-31): EPS=3.65 | Chg7d=+0.097 | Chg30d=+0.079 | Revisions Net=+8 | Growth EPS=+12.4% | Growth Revenue=+6.3%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.1% (Discount Rate 11.8% - Earnings Yield 3.7%)
[Growth] Growth Spread = -1.2% (Analyst 6.9% - Implied 8.1%)
P/E Forward = 16.2866
P/S = 0.8256
P/B = 4.2999
P/EG = 0.9351
Revenue TTM = 26.84b USD
EBIT TTM = 942.0m USD
EBITDA TTM = 1.76b USD
Long Term Debt = 3.76b USD (from longTermDebt, last quarter)
Short Term Debt = 675.0m USD (from shortTermDebt, last quarter)
Debt = 5.60b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.54b USD (from netDebt column, last quarter)
Enterprise Value = 24.70b USD (22.15b + Debt 5.60b - CCE 3.06b)
Interest Coverage Ratio = 4.55 (Ebit TTM 942.0m / Interest Expense TTM 207.0m)
EV/FCF = 21.25x (Enterprise Value 24.70b / FCF TTM 1.16b)
FCF Yield = 4.70% (FCF TTM 1.16b / Enterprise Value 24.70b)
FCF Margin = 4.33% (FCF TTM 1.16b / Revenue TTM 26.84b)
Net Margin = 3.17% (Net Income TTM 852.0m / Revenue TTM 26.84b)
Gross Margin = 9.07% ((Revenue TTM 26.84b - Cost of Revenue TTM 24.40b) / Revenue TTM)
Gross Margin QoQ = 9.71% (prev 9.02%)
Tobins Q-Ratio = 1.19 (Enterprise Value 24.70b / Total Assets 20.82b)
Interest Expense / Debt = 1.04% (Interest Expense 58.0m / Debt 5.60b)
Taxrate = 25.31% (81.0m / 320.0m)
NOPAT = 703.6m (EBIT 942.0m * (1 - 25.31%))
Current Ratio = 1.40 (Total Current Assets 15.15b / Total Current Liabilities 10.86b)
Debt / Equity = 1.09 (Debt 5.60b / totalStockholderEquity, last quarter 5.12b)
Debt / EBITDA = 1.45 (Net Debt 2.54b / EBITDA 1.76b)
Debt / FCF = 2.19 (Net Debt 2.54b / FCF TTM 1.16b)
Total Stockholder Equity = 5.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.36% (Net Income 852.0m / Total Assets 20.82b)
RoE = 16.83% (Net Income TTM 852.0m / Total Stockholder Equity 5.06b)
RoCE = 10.68% (EBIT 942.0m / Capital Employed (Equity 5.06b + L.T.Debt 3.76b))
RoIC = 7.87% (NOPAT 703.6m / Invested Capital 8.94b)
WACC = 9.56% (E(22.15b)/V(27.76b) * Re(11.78%) + D(5.60b)/V(27.76b) * Rd(1.04%) * (1-Tc(0.25)))
Discount Rate = 11.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.14%
[DCF] Terminal Value 76.37% ; FCFF base≈1.23b ; Y1≈1.52b ; Y5≈2.59b
[DCF] Fair Price = 83.53 (EV 33.26b - Net Debt 2.54b = Equity 30.71b / Shares 367.7m; r=9.56% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 42.45 | EPS CAGR: 14.71% | SUE: 1.45 | # QB: 1
Revenue Correlation: -32.56 | Revenue CAGR: 0.80% | SUE: 0.95 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.83 | Chg7d=+0.021 | Chg30d=+0.020 | Revisions Net=+4 | Analysts=6
EPS next Year (2027-03-31): EPS=3.65 | Chg7d=+0.097 | Chg30d=+0.079 | Revisions Net=+8 | Growth EPS=+12.4% | Growth Revenue=+6.3%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.1% (Discount Rate 11.8% - Earnings Yield 3.7%)
[Growth] Growth Spread = -1.2% (Analyst 6.9% - Implied 8.1%)